Skip to main content
. 2022 Oct 31;14:137. doi: 10.1186/s13148-022-01354-z

Table 4.

Association between cg12869254 with OCT/A measurements in univariable and multivariable linear regression models

OCT/A measurements* Univariable model 1 Multivariable model 2§
β 95% CI P value† β 95% CI P value
SCP VD, %
 Superior 0.4 (− 1.6, 2.2) 0.695 − 0.2 (− 2.5, 2.0) 0.828
 Inferior − 0.6 (− 3.0, 1.7) 0.582 − 0.3 (− 3.5, 2.9) 0.839
 Nasal 1.4 (− 0.6, 3.3) 0.164 1.3 (1.0, 3.6) 0.241
 Temporal 0.01 (− 2.7, 2.7) 0.990 − 1.7 (− 5.3, 1.9) 0.321
DCP VD, %
 Superior 0.1 (− 1.0, 1.1) 0.895 0.2 (− 1.1, 1.5) 0.728
 Inferior − 0.7 (− 2.1, 0.7) 0.322 0.1 (− 2.0, 2.2) 0.917
 Nasal − 0.2 (− 1.3, 0.9) 0.702 0.2 (− 1.1, 1.5) 0.806
 Temporal − 0.8 (− 2.5, 0.9) 0.334 − 0.7 (− 2.7, 1.3) 0.444
RNFL thickness, µm
 Superior − 2.6 (− 5.1, − 0.2) 0.039 − 3.0 (− 5.8, − 0.2) 0.035
 Inferior − 0.4 (− 2.4, 1.6) 0.666 0.3 (− 2.4, 3.0) 0.790
 Nasal − 2.6 (− 4.4, − 0.7) 0.009 − 2.2 (− 4.4, − 0.1) 0.049
 Temporal 0.2 (− 2.0, 2.4) 0.843 0.4 (− 2.1, 2.8) 0.749

OCT/A = optical coherence tomography/angiography; SCP = superficial capillary plexus; VD = vessel density; DCP = deep capillary plexus; RNFL = retinal nerve fiber layer; CI = confidential interval; T2DM = type 2 diabetes mellitus; HbA1c = glycated hemoglobin

§Adjusted for age, sex, T2DM duration and HbA1c. *Per percent of methylation change. Bold indicates statistically significant